Tatiana W Spirtos, MD
Obstetrics/Gynecology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 4 carriers
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Spirtos’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G45093 · Current
Licensed to practise in California · since 1981 · expires 2029-01-31 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$39,136
Medicare paid this office $39,136 for 218 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 93 | $13,257 | $112 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 95 | $5,393 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 88 | $4,170 | $47 |
| New patient visit (30+ min) | 40 | $3,844 | $96 |
| Short return visit (20+ min) | 14 | $873 | $62 |
See all 7 services
| Return visit (30+ min) | 93 | $13,257 | $112 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 95 | $5,393 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 88 | $4,170 | $47 |
| New patient visit (30+ min) | 40 | $3,844 | $96 |
| Short return visit (20+ min) | 14 | $873 | $62 |
| Limited ultrasound scan of pelvis | 14 | $795 | $50 |
| Urinalysis, manual test | 11 | $38 | $3 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
218 Original Medicare patients in 2024. Average age 74 · Women 100% · Health risk score 0.59. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 48% · Coronary heart disease 17% · Cancer 12% · Depression 12% · Atrial fibrillation 11% · Diabetes 10% · Chronic kidney disease 6% · Heart failure 5% · Stroke 5%.
The office billed $173,643, Medicare allowed $49,513 and paid $39,136; for 458 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 218 | 458 | 74 | 0.59 | $173,643 | $39,136 |
| 2023 | 205 | 415 | 74 | 0.69 | $133,070 | $32,742 |
| 2022 | 219 | 434 | 73 | 0.69 | $141,448 | $31,044 |
| 2021 | 218 | 436 | 73 | 0.69 | $152,096 | $31,521 |
| 2020 | 187 | 340 | 73 | 0.73 | $103,388 | $21,936 |
| 2019 | 226 | 442 | 72 | 0.79 | $165,204 | $31,653 |
| 2018 | 197 | 343 | 73 | 0.74 | $112,642 | $21,827 |
| 2017 | 202 | 390 | 73 | 0.70 | $103,769 | $24,761 |
| 2016 | 233 | 373 | 74 | 0.71 | $69,072 | $27,737 |
| 2015 | 236 | 324 | 73 | 0.73 | $52,716 | $32,534 |
| 2014 | 261 | 357 | 73 | 0.79 | $66,068 | $37,912 |
| 2013 | 250 | 344 | 72 | 0.68 | $64,236 | $33,165 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 73 | $10,157 | $114 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 95 | $5,193 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 86 | $4,032 | $47 |
| New patient visit (30+ min) | 43 | $3,730 | $87 |
| Short return visit (20+ min) | 15 | $1,270 | $79 |
| Limited ultrasound scan of pelvis | 18 | $876 | $46 |
2022: 9 services
| Return visit (30+ min) | 61 | $7,240 | $106 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 100 | $5,331 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 92 | $4,269 | $46 |
| Short return visit (20+ min) | 33 | $2,825 | $74 |
| New patient visit (30+ min) | 35 | $2,786 | $80 |
| New patient visit (45+ min) | 13 | $1,830 | $141 |
| Limited ultrasound scan of pelvis | 17 | $805 | $45 |
| Administration of influenza virus vaccine | 12 | $433 | $36 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $253 | $21 |
2021: 6 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 109 | $5,882 | $54 |
| Return visit (30+ min) | 45 | $5,238 | $114 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 101 | $4,755 | $47 |
| Short return visit (20+ min) | 40 | $3,594 | $73 |
| New patient visit (30+ min) | 37 | $3,331 | $90 |
| Urinalysis, manual test | 12 | $45 | $3 |
2020: 7 services
| Short return visit (20+ min) | 65 | $4,655 | $60 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 64 | $3,419 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 67 | $3,169 | $47 |
| Return visit (30+ min) | 23 | $2,166 | $90 |
| New patient visit (30+ min) | 24 | $2,029 | $85 |
| Short return visit | 15 | $662 | $39 |
| Limited ultrasound scan of pelvis | 14 | $622 | $44 |
2019: 8 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 106 | $4,865 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 90 | $4,772 | $53 |
| Short return visit (20+ min) | 64 | $4,616 | $62 |
| Return visit (30+ min) | 43 | $4,269 | $91 |
| New patient visit (30+ min) | 20 | $1,934 | $97 |
| Biopsy of lining of uterus | 11 | $951 | $86 |
| Limited ultrasound scan of pelvis | 17 | $851 | $43 |
| Short return visit | 13 | $475 | $37 |
2018: 6 services
| Return visit (30+ min) | 47 | $3,826 | $81 |
| Short return visit (20+ min) | 53 | $3,535 | $54 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 54 | $2,735 | $51 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 64 | $2,678 | $42 |
| New patient visit (30+ min) | 16 | $1,355 | $85 |
| Short return visit | 17 | $502 | $28 |
2017: 6 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 108 | $4,604 | $43 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 86 | $4,438 | $52 |
| Short return visit (20+ min) | 50 | $3,032 | $55 |
| Return visit (30+ min) | 26 | $2,537 | $94 |
| New patient visit (30+ min) | 13 | $1,034 | $80 |
| Short return visit | 13 | $352 | $27 |
2016: 7 services
| Long return visit (40+ min) | 71 | $7,787 | $110 |
| Short return visit (20+ min) | 51 | $3,705 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 65 | $2,852 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 46 | $2,474 | $54 |
| Return visit (30+ min) | 19 | $1,902 | $95 |
| Short return visit | 27 | $1,165 | $36 |
| New patient visit (30+ min) | 12 | $1,087 | $91 |
2015: 3 services
| Long return visit (40+ min) | 148 | $16,170 | $109 |
| Short return visit (20+ min) | 62 | $5,077 | $56 |
| Return visit (30+ min) | 25 | $2,059 | $79 |
2014: 3 services
| Long return visit (40+ min) | 162 | $16,799 | $104 |
| Short return visit (20+ min) | 55 | $4,782 | $59 |
| Return visit (30+ min) | 29 | $2,668 | $86 |
2013: 4 services
| Long return visit (40+ min) | 157 | $16,985 | $108 |
| Short return visit (20+ min) | 41 | $3,678 | $57 |
| Return visit (30+ min) | 42 | $3,388 | $75 |
| New patient visit (45+ min) | 13 | $1,775 | $137 |
Drugs they prescribed that Part D paid
$86,305
Pharmacies billed $86,305 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (11 of 552) in 2024. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
455 generic and 97 brand-name prescriptions · $86,305 in drug cost · 16 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 155 | $14,810 | $96 |
| Myrbetriq | 16 | $12,234 | $765 |
| Premarin | 11 | $9,011 | $819 |
| Estring | 16 | $8,091 | $506 |
| Yuvafem | 28 | $4,984 | $178 |
See all 16 drugs
| Estradiol | 155 | $14,810 | $96 |
| Myrbetriq | 16 | $12,234 | $765 |
| Premarin | 11 | $9,011 | $819 |
| Estring | 16 | $8,091 | $506 |
| Yuvafem | 28 | $4,984 | $178 |
| Estradiol (Twice Weekly) | 33 | $3,868 | $117 |
| Estradiol-Norethindrone Acetat | 18 | $2,031 | $113 |
| Dotti | 15 | $1,850 | $123 |
| Progesterone | 38 | $1,686 | $44 |
| Valacyclovir | 22 | $1,360 | $62 |
| Clobetasol Propionate | 26 | $1,318 | $51 |
| Hydroxyzine | 11 | $320 | $29 |
| Acyclovir | 11 | $113 | $10 |
| Fluconazole | 16 | $69 | $4 |
| Oxycodone-Acetaminophen | 11 | $46 | $4 |
| Triamcinolone Acetonide | 12 | $30 | $2 |
Year by year
| 2024 | 552 | 167 | 2% (11) | 18% | $86,305 |
| 2023 | 500 | 156 | None | None | $106,022 |
| 2022 | 497 | 145 | None | 26% | $109,008 |
| 2021 | 466 | 152 | None | None | $89,397 |
| 2020 | 495 | 128 | None | None | $98,652 |
| 2019 | 436 | 129 | None | 23% | $82,547 |
| 2018 | 391 | 117 | None | 24% | $63,791 |
| 2017 | 435 | 124 | None | None | $77,294 |
| 2016 | 388 | 107 | None | 37% | $66,728 |
| 2015 | 361 | 101 | None | 41% | $56,091 |
| 2014 | 436 | 125 | None | None | $64,716 |
| 2013 | 559 | 133 | 0% (0) | 45% | $59,823 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Estradiol | 142 | $22,754 | $160 |
| Premarin | 17 | $12,068 | $710 |
| Estring | 20 | $10,853 | $543 |
| Combipatch | 22 | $9,584 | $436 |
| Oxytrol | 12 | $8,018 | $668 |
| Yuvafem | 28 | $6,466 | $231 |
| Estradiol (Twice Weekly) | 11 | $2,230 | $203 |
| Valacyclovir | 21 | $2,129 | $101 |
| Dotti | 11 | $1,720 | $156 |
| Clobetasol Propionate | 25 | $1,375 | $55 |
| Progesterone | 21 | $1,042 | $50 |
| Fluconazole | 20 | $161 | $8 |
2022: 10 drugs
| Estradiol | 161 | $23,282 | $145 |
| Premarin | 24 | $15,387 | $641 |
| Estring | 19 | $9,449 | $497 |
| Yuvafem | 24 | $6,600 | $275 |
| Estradiol (Twice Weekly) | 26 | $4,083 | $157 |
| Valacyclovir | 27 | $2,622 | $97 |
| Estradiol-Norethindrone Acetat | 12 | $2,450 | $204 |
| Prempro | 14 | $1,966 | $140 |
| Progesterone | 26 | $1,783 | $69 |
| Triamcinolone Acetonide | 16 | $132 | $8 |
2021: 10 drugs
| Estradiol | 159 | $22,342 | $141 |
| Premarin | 27 | $15,539 | $576 |
| Estring | 15 | $6,889 | $459 |
| Yuvafem | 19 | $4,638 | $244 |
| Valacyclovir | 18 | $2,086 | $116 |
| Estradiol (Twice Weekly) | 13 | $2,022 | $156 |
| Progesterone | 21 | $1,836 | $87 |
| Clobetasol Propionate | 16 | $1,121 | $70 |
| Nitrofurantoin Mono-Macro | 16 | $364 | $23 |
| Fluconazole | 14 | $167 | $12 |
2020: 12 drugs
| Estradiol | 141 | $22,274 | $158 |
| Premarin | 21 | $11,980 | $570 |
| Estrace | 23 | $8,427 | $366 |
| Estring | 17 | $7,591 | $447 |
| Progesterone | 50 | $5,510 | $110 |
| Estradiol (Twice Weekly) | 21 | $2,759 | $131 |
| Yuvafem | 11 | $2,387 | $217 |
| Valacyclovir | 20 | $1,994 | $100 |
| Dotti | 12 | $1,294 | $108 |
| Clobetasol Propionate | 11 | $492 | $45 |
| Nitrofurantoin Mono-Macro | 13 | $411 | $32 |
| Fluconazole | 11 | $133 | $12 |
2019: 9 drugs
| Estradiol | 151 | $23,211 | $154 |
| Premarin | 15 | $8,395 | $560 |
| Estring | 17 | $7,224 | $425 |
| Estrace | 19 | $6,596 | $347 |
| Progesterone | 32 | $3,084 | $96 |
| Yuvafem | 12 | $2,745 | $229 |
| Metronidazole | 18 | $2,592 | $144 |
| Estradiol-Norethindrone Acetat | 11 | $1,542 | $140 |
| Clobetasol Propionate | 12 | $691 | $58 |
2018: 10 drugs
| Estradiol | 104 | $13,809 | $133 |
| Estrace | 25 | $8,459 | $338 |
| Yuvafem | 31 | $6,286 | $203 |
| Premarin | 14 | $6,245 | $446 |
| Estring | 13 | $5,304 | $408 |
| Progesterone | 23 | $2,161 | $94 |
| Valacyclovir | 15 | $1,416 | $94 |
| Lopreeza | 12 | $1,283 | $107 |
| Clobetasol Propionate | 16 | $1,079 | $67 |
| Acyclovir | 12 | $81 | $7 |
2017: 10 drugs
| Estrace | 65 | $19,049 | $293 |
| Yuvafem | 36 | $11,418 | $317 |
| Premarin | 21 | $7,356 | $350 |
| Estradiol | 69 | $5,604 | $81 |
| Estring | 13 | $4,939 | $380 |
| Prempro | 16 | $4,502 | $281 |
| Clobetasol Propionate | 23 | $2,696 | $117 |
| Progesterone | 18 | $1,472 | $82 |
| Valacyclovir | 11 | $1,371 | $125 |
| Lorazepam | 12 | $52 | $4 |
2016: 9 drugs
| Estrace | 42 | $13,016 | $310 |
| Vagifem | 32 | $11,026 | $345 |
| Premarin | 27 | $8,528 | $316 |
| Prempro | 23 | $6,700 | $291 |
| Estring | 16 | $4,919 | $307 |
| Clobetasol Propionate | 23 | $3,629 | $158 |
| Estradiol | 73 | $2,841 | $39 |
| Progesterone | 18 | $1,643 | $91 |
| Valacyclovir | 12 | $1,043 | $87 |
2015: 8 drugs
| Estrace | 39 | $10,297 | $264 |
| Premarin | 32 | $8,356 | $261 |
| Vagifem | 20 | $7,145 | $357 |
| Estring | 23 | $5,850 | $254 |
| Prempro | 23 | $5,039 | $219 |
| Clobetasol Propionate | 23 | $4,500 | $196 |
| Estradiol | 41 | $2,671 | $65 |
| Alendronate | 12 | $111 | $9 |
2014: 9 drugs
| Premarin | 43 | $11,287 | $262 |
| Estrace | 48 | $11,027 | $230 |
| Vagifem | 31 | $7,236 | $233 |
| Estring | 29 | $6,502 | $224 |
| Vivelle-Dot | 26 | $4,735 | $182 |
| Prempro | 26 | $3,862 | $149 |
| Estradiol | 32 | $1,367 | $43 |
| Clobetasol Propionate | 11 | $1,175 | $107 |
| Levothyroxine | 11 | $345 | $31 |
2013: 13 drugs
| Premarin | 54 | $8,849 | $164 |
| Estrace | 51 | $8,370 | $164 |
| Vagifem | 38 | $6,495 | $171 |
| Estring | 26 | $5,307 | $204 |
| Detrol La | 12 | $4,540 | $378 |
| Vivelle-Dot | 19 | $3,243 | $171 |
| Estradiol-Norethindrone Acetat | 11 | $2,027 | $184 |
| Estradiol | 45 | $1,604 | $36 |
| Progesterone | 14 | $1,473 | $105 |
| Clobetasol Propionate | 27 | $603 | $22 |
| Levothyroxine | 23 | $390 | $17 |
| Medroxyprogesterone Acetate | 15 | $96 | $6 |
| Zolpidem | 17 | $83 | $5 |
Money from drug and device companies
$20 in 2024
A payment is not proof that care is biased.
| Becton Dickinson and | None | $20 | 1 payment
|
See the published payment
| Becton Dickinson and | Meals · 2024-09-25 | None | $20 |
Professional record
- NPI
- 1710903133
- Licence
- CA G45093California G45093: Current · expires 2029-01-31
- Trained
- Northwestern University Feinberg Medical School, 1980
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2900 Whipple Ave, #135, Redwood City, CA, 94062
- NPI first listed
- 2006-07-15
- NPI last updated
- 2011-09-16
This is when the NPI record was last certified, not a medical board exam.